The pharmaceutical industry faces a significant blind spot in its marketing strategies, as a substantial portion of newly prescribed medications are never filled. This gap occurs after a physician writes a prescription, with decisions made at the pharmacy counter regarding cost, coverage, and substitution often leading to prescription abandonment. Studies indicate that up to 28% of new prescriptions are not filled, with abandonment rates for cancer therapies climbing significantly with higher out-of-pocket costs. The industry has historically focused its marketing efforts on physicians and waiting rooms, neglecting the crucial point of decision-making at the pharmacy, where timely information could influence patient adherence and therapy outcomes. AI
RANK_REASON Opinion piece by an industry executive discussing a strategic gap in pharmaceutical marketing.
- Brigham and Women's Hospital
- Doceree Inc.
- Harshit Jain
- Journal of Clinical Oncology
- Journal of General Internal Medicine
- Massachusetts General Hospital
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →